A Detailed Analysis of the Murine TAP Transporter Substrate Specificity

Background The transporter associated with antigen processing (TAP) supplies cytosolic peptides into the endoplasmic reticulum for binding to major histocompatibility complex (MHC) class I molecules. Its specificity therefore influences the repertoire of peptides presented by MHC molecules. Compared to human TAP, murine TAP's binding specificity has not been characterized as well, even though murine systems are widely used for basic studies of antigen processing and presentation. Methodology/Principal Findings We performed a detailed experimental analysis of murine TAP binding specificity by measuring the binding affinities of 323 peptides. Based on this experimental data, a computational model of murine TAP specificity was constructed. The model was compared to previously generated data on human and murine TAP specificities. In addition, the murine TAP specificities for known epitopes and random peptides were predicted and compared to assess the impact of murine TAP selectivity on epitope selection. Conclusions/Significance Comparisons to a previously constructed model of human TAP specificity confirms the well-established differences for peptide substrates with positively charged C-termini. In addition these comparisons show that several residues at the N-terminus of peptides which strongly influence binding to human TAP showed little effect on binding to murine TAP, and that the overall influence of the aminoterminal residues on peptide affinity for murine TAP is much lower than for the human transporter. Murine TAP also partly prefers different hydrophobic amino acids than human TAP in the carboxyterminal position. These species-dependent differences in specificity determined in vitro are shown to correlate with the epitope repertoire recognized in vivo. The quantitative model of binding specificity of murine TAP developed herein should be useful for interpreting epitope mapping and immunogenicity data obtained in humanized mouse models.

[1]  Clemencia Pinilla,et al.  Characterization of the peptide-binding specificity of the chimpanzee class I alleles A*0301 and A*0401 using a combinatorial peptide library , 2007, Immunogenetics.

[2]  Julie A McMurry,et al.  Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice. , 2007, Current molecular medicine.

[3]  Bjoern Peters,et al.  The CD8+ T-Cell Response to Lymphocytic Choriomeningitis Virus Involves the L Antigen: Uncovering New Tricks for an Old Virus , 2007, Journal of Virology.

[4]  Bjoern Peters,et al.  Immune epitope mapping in the post-genomic era: lessons for vaccine development. , 2007, Current opinion in immunology.

[5]  Magdalini Moutaftsi,et al.  A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus , 2006, Nature Biotechnology.

[6]  J. Drijfhout,et al.  Cutting Edge: HLA-B27 Acquires Many N-Terminal Dibasic Peptides: Coupling Cytosolic Peptide Stability to Antigen Presentation1 , 2006, The Journal of Immunology.

[7]  A. Goldberg,et al.  The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a "molecular ruler" mechanism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  C. Walker,et al.  Adaptive immune responses in acute and chronic hepatitis C virus infection , 2005, Nature.

[9]  S. Pascolo.  HLA class I transgenic mice: development, utilisation and improvement , 2005, Expert opinion on biological therapy.

[10]  Alessandro Sette,et al.  Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method , 2005, BMC Bioinformatics.

[11]  L. Schomburg,et al.  Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum , 2005, Nature Immunology.

[12]  H. Goldschmidt,et al.  Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma. , 2005, Blood.

[13]  M. Fernandez-Vina,et al.  Identification of a Human HLA-E-Restricted CD8+ T Cell Subset in Volunteers Immunized with Salmonella enterica Serovar Typhi Strain Ty21a Typhoid Vaccine1 , 2004, The Journal of Immunology.

[14]  S. Swain,et al.  T cell responses to influenza virus infection: effector and memory cells. , 2004, Viral immunology.

[15]  Jacques Neefjes,et al.  A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. , 2004, Immunity.

[16]  N. Glaichenhaus,et al.  Mini‐review: Presentation of pathogen‐derived antigens in vivo , 2004, European journal of immunology.

[17]  S Brunak,et al.  Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. , 2003, Tissue antigens.

[18]  Bjoern Peters,et al.  Identifying MHC Class I Epitopes by Predicting the TAP Transport Efficiency of Epitope Precursors , 2003, The Journal of Immunology.

[19]  C. Diaz-Montero,et al.  Identification of CD8 T-Lymphocyte Epitopes in OmpB of Rickettsia conorii , 2003, Infection and Immunity.

[20]  F. Ginhoux,et al.  Quantifying Recruitment of Cytosolic Peptides for HLA Class I Presentation: Impact of TAP Transport1 , 2003, The Journal of Immunology.

[21]  Shu-Bing Qian,et al.  Quantitating protein synthesis, degradation, and endogenous antigen processing. , 2003, Immunity.

[22]  Concepción Marañón,et al.  An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope , 2003, Nature Immunology.

[23]  Naoki Abe,et al.  Empirical Evaluation of a Dynamic Experiment Design Method for Prediction of MHC Class I-Binding Peptides1 , 2002, The Journal of Immunology.

[24]  P. van Endert,et al.  Powering the peptide pump: TAP crosstalk with energetic nucleotides. , 2002, Trends in biochemical sciences.

[25]  F. Wong,et al.  Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. , 2002, Immunity.

[26]  N. Shastri,et al.  Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. , 2002, Annual review of immunology.

[27]  J. Neefjes,et al.  Export of antigenic peptides from the endoplasmic reticulum intersects with retrograde protein translocation through the Sec61p channel. , 2000, Immunity.

[28]  J. McCluskey,et al.  Distinct Functions of Tapasin Revealed by Polymorphism in MHC Class I Peptide Loading1 , 2000, The Journal of Immunology.

[29]  V Brusic,et al.  Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules. , 1998, Journal of immunology.

[30]  P. van Endert,et al.  Substrate selection by transporters associated with antigen processing occurs during peptide binding to TAP. , 1998, Molecular immunology.

[31]  H. Dockrell,et al.  Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  P. Doherty,et al.  Effector CD4+ and CD8+ T‐cell mechanisms in the control of respiratory virus infections , 1997, Immunological reviews.

[33]  S Uebel,et al.  Recognition principle of the TAP transporter disclosed by combinatorial peptide libraries. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Neefjes,et al.  The rational design of TAP inhibitors using peptide substrate modifications and peptidomimetics , 1997, European journal of immunology.

[35]  A Sette,et al.  The peptide-binding motif for the human transporter associated with antigen processing , 1995, The Journal of experimental medicine.

[36]  R. Obst,et al.  Analysis of the fine specificity of rat, mouse and human TAP peptide transporters , 1995, European journal of immunology.

[37]  H. Ploegh,et al.  Substrate specificity of allelic variants of the TAP peptide transporter. , 1994, Immunity.

[38]  J. Neefjes,et al.  Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling , 1994, The Journal of experimental medicine.

[39]  R. Tampé,et al.  A sequential model for peptide binding and transport by the transporters associated with antigen processing. , 1994, Immunity.

[40]  J. Neefjes,et al.  Peptide size selection by the major histocompatibility complex-encoded peptide transporter , 1994, The Journal of experimental medicine.

[41]  Günter J. Hämmerling,et al.  Selectivity of MHC-encoded peptide transporters from human, mouse and rat , 1994, Nature.

[42]  J. Neefjes,et al.  Peptide selection by MHC-encoded TAP transporters. , 1994, Current opinion in immunology.

[43]  S. Tonegawa,et al.  Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator , 1994, The Journal of experimental medicine.

[44]  E. Pamer,et al.  Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope. , 1994, Journal of immunology.

[45]  T. Schumacher,et al.  Peptide translocation by variants of the transporter associated with antigen processing. , 1993, Science.

[46]  J. Neefjes,et al.  Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. , 1993, Science.

[47]  C. Higgins,et al.  ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.